Literature DB >> 6860512

Serum creatine kinase and creatine kinase MB isoenzyme responses of post-infarction patients after a graded exercise test.

B Davies, D A Watt, A Daggett.   

Abstract

The response of total creatine kinase (CK) and the creatine kinase isoenzyme (CK MB) was studied in 22 male post-infarction patients (three to six months after myocardial infarction) after a functional graded exercise test, before entering a rehabilitation programme. Eleven subjects (group A) completed the test without developing significant electrocardiographic abnormalities. Eleven subjects (group B) showed changes that necessitated premature termination of the test. No significant differences were observed before the functional graded exercise test between the groups in serum concentration of CK, CK MB, and the percentage of CK MB to CK (MB/ CK%). The two groups were significantly different (p less than 0.01) 24 hours after the graded exercise test in CK MB and MB/CK%, but not in CK. In group B, CK and CK MB rose significantly after the graded exercise test (p less than 0.05) as did MB/CK% (p less than 0.01). In group A only CK showed a significant rise (p less than 0.05). It is probable that increases in CK MB after exercise arise from myocardial tissue efflux, reflecting reversible ischaemia. It is concluded from this study that CK MB appears to be a specific indicator of myocardial ischaemia and could, therefore, be of significant assistance in the clinical and functional assessment of the post-infarction patient.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860512      PMCID: PMC481372          DOI: 10.1136/hrt.50.1.65

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  26 in total

1.  Enzyme release resulting from total ischemia and reperfusion in the isolated, perfused guinea pig heart.

Authors:  K Sakai; M M Gebhard; P G Spieckermann; H J Bretschneider
Journal:  J Mol Cell Cardiol       Date:  1975-11       Impact factor: 5.000

2.  The effects of training on heart rate; a longitudinal study.

Authors:  M J KARVONEN; E KENTALA; O MUSTALA
Journal:  Ann Med Exp Biol Fenn       Date:  1957

3.  Determination of creatine kinase isoenzyme MB (CK-MB): comparison of methods and clinical evaluation.

Authors:  J W Fiolet; A F Willebrands; K I Lie; H F ter Welle
Journal:  Clin Chim Acta       Date:  1977-10-01       Impact factor: 3.786

4.  New criteria to enhance the predictability of coronary artery disease by exercise testing in asymptomatic subjects.

Authors:  E C Lozner; J Morganroth
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

Review 5.  Exercise stress testing.

Authors:  N J Fortuin; J L Weiss
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

Review 6.  Creatine kinase isoenzymes in the assessment of heart disease.

Authors:  R Roberts; B E Sobel
Journal:  Am Heart J       Date:  1978-04       Impact factor: 4.749

7.  Separation of tissue and serum creatine kinase isoenzymes by ion-exchange column chromatography.

Authors:  D W Mercer
Journal:  Clin Chem       Date:  1974       Impact factor: 8.327

8.  Meaning of elevated CK-MB.

Authors:  D Lindsey; T Navin; P Finley
Journal:  Am Heart J       Date:  1979-09       Impact factor: 4.749

9.  Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction.

Authors:  R Roberts; K S Gowda; P A Ludbrook; B E Sobel
Journal:  Am J Cardiol       Date:  1975-10-06       Impact factor: 2.778

10.  The significance of the MB isoenzyme in patients with acute cardiovascular disease with a normal or borderline total CPK activity.

Authors:  J P D'Souza; H E Sine; R A Horvitz; N P Kubasik; B B Brody; S S Barold
Journal:  Clin Biochem       Date:  1978-10       Impact factor: 3.281

View more
  1 in total

1.  Serum creatine kinase activity following repeated bouts of isometric exercise with different muscle groups.

Authors:  J E Graves; P M Clarkson; P Litchfield; J P Kirwan; J P Norton
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.